Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Ross Stores (ROST – Research Report), Lifetime Brands ...

After previously collaborating with the House of Mouse, the Hundreds co-founder will now oversee merchandise and licensed ...

Canadian consumers are responding to U.S. tariffs and presidential musings of annexation with a “Buy Canadian” movement that ...

Brand representatives working across all walks of life, from airlines to children's medicine to kettles, gathered on Thursday night to celebrate winning Newsweek /BrandSpark's Most Trusted U.K. Brands ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...

Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.

Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...

Following Pfizer's disposal, BlackRock Investment Management (UK) Ltd, a unit of BlackRock, will become Haleon's largest ...

UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025.The rebrand comes after GSK transferred its consumer health business to Haleon to focus on ...